What factors affect the combined dosage?

There are no factors affecting the dosage of the combinent® because, regardless of age, weight, existing health conditions or current medicines, there is only one standard dose. The standard dosage of combined® is two inhalation sprays, four times a day. The combined and reg is used in the treatment of chronic obstructive lung disease (COPD), which includes bronchitis and emphysema. The drugs are working to remain narrowed by the airways open and facilitate breathing. In addition, it can cause chest tightness and significant cough. Although smoking is the main cause of the condition, other causes can contribute to it. COPD can generally be well controlled, but pulmonary damage that can cause can usually not be turned. Ending smoking can offer an important advantage in the treatment of COPD and prevent further damage to lung tissue.

Other treatments that can be administered in addition to the standard dosage of combined® are inhalation steroids, pneumococcal vaccine, bronchodilators and annual flu shot. INDepending on the severity of the symptoms, the healthcare provider may recommend more or less standard doses. It is important that patients never modify the Kotent® dosage themselves without consulting their healthcare providers first.

Standard dose Combinent® can cause side effects such as upper respiratory tract infections, bronchitis and headaches. In addition, it can combine and reg cause chronic cough, nausea, difficulty breathing and sore throat. Sinus infections, flu -like signs and rhinitis or clogged nose are also common side effects. When the side effects on this medicine become serious, the healthcare provider can think of another treatment plan to help alleviate symptoms.

Rare and sometimes serious side effects of standard dosing of combined® include wheezing, chest pain and shortness of breath. Other rare but serious effects can fromAhrins dangerously high or low blood pressure, diabetes exacerbation and irregular heart rhythm. If any of these symptoms occurs, emergency medical intervention may reduce the risk of complications.

Combinvent & Reg has not been determined for use in women who are pregnant or considered pregnancy or for those who are breastfeeding. The use of this medicine may disrupt the fetal development and may increase blood sugar levels on fruits. Women with COPD should discuss alternative treatments with their healthcare providers. Other treatment can help reduce the symptoms of COPD, which may pose a small threat to a mother or child.